Skip to main content

Advertisement

Log in

Feasibility of aspirin continuation during the perioperative period for pulmonary resection in lung cancer patients: a retrospective study at a single institute in Japan

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the feasibility of aspirin continuation during the perioperative period for pulmonary resection in lung cancer patients.

Methods

A retrospective study was conducted in 46 patients who were taking aspirin and underwent pulmonary resection. The indications for aspirin were generally a cardiovascular or cerebrovascular comorbidity. Whether to continue or discontinue aspirin was determined based on the severity of the cardiovascular or cerebrovascular comorbidity, along with the patient’s overall condition. The intraoperative and postoperative outcomes were compared between patients continuing and those discontinuing aspirin.

Results

Twenty patients continued (group C) and 26 patients discontinued (group D) aspirin. The length of the operation (226 ± 97 min in group C vs. 189 ± 90 min in group D), intraoperative bleeding (234 ± 232 vs. 204 ± 367 g) and average pleural discharge on postoperative days 1, 2 and 3 (331, 230 and 215 vs. 304, 210 and 174 ml/day) showed no significant differences between the two groups. The postoperative complication rates were also not significantly different between the two groups [eight patients (40 %) in group C vs. nine patients (35 %) in group D].

Conclusions

Continuous administration of aspirin during the perioperative period for pulmonary resection in lung cancer patients appears to be clinically feasible in the Japanese population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Endo H, Yamamoto R, Satoh Y, Kuwano H, Nishizawa N. Risk analysis of pulmonary resection for elderly patients with lung cancer. Surg Today. 2013;43:514–20.

    Article  Google Scholar 

  2. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86.

    Article  Google Scholar 

  3. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519–21.

    Article  CAS  PubMed  Google Scholar 

  4. Sonobe M, Sato T, Chen F, Fujinaga T, Shoji T, Sakai H, et al. Management of patients with coronary stents in elective thoracic surgery. Gen Thorac Cardiovasc Surg. 2011;59:477–82.

    Article  PubMed  Google Scholar 

  5. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:299S–339S.

    Article  CAS  PubMed  Google Scholar 

  7. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007;116:1971–96.

    Article  PubMed  Google Scholar 

  8. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J. 2009;30:2769–812.

    Article  PubMed  Google Scholar 

  9. Saunders E, Ofili E. Epidemiology of atherothrombotic disease and the effectiveness and risks of antiplatelet therapy: race and ethnicity considerations. Cardiol Rev. 2008;16:82–8.

    Article  PubMed  Google Scholar 

  10. Kobayashi H. Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery. J Cataract Refract Surg. 2010;36:1115–9.

    Article  PubMed  Google Scholar 

  11. Shinkai A, Matsumoto Y, Chikuda M. Evaluation of patients undergoing vitreous surgery while on antithrombotic therapy (in Japanese with English abstract). Gannka Rinsho Kiyo (Folia Japonica de Ophthalmologica). 2011;4:433–6.

    Google Scholar 

  12. Ohmiya H, Okajima K, Abe Y, Tanoue M, Murakami N, Mori S. Anticoagulant during perioperative stage of spinal surgery (in Japanese with English abstract). Orthop Traumatol. 2007;56:214–6.

    Article  Google Scholar 

  13. Murase A, Yoshida I, Shibata Y, Kawanishi T, Kojima H, Kuroyanagi H. A study of the continuation of aspirin in proximal femoral fracture patients (in Japanese). Central Jpn J Orthop Surg Traumatol. 2011;54:291–2.

    Google Scholar 

  14. Tsukahara A, Maruta T, Koyama S, Tanaka N, Takeda N, Shimoda S. Koukesshoubannryouhoushourei ni taisuru shoukakigekashujutu (in Japanese). In: Abstract of the 67th general meeting of the Japanese Society of Gastroenterological Surgery, pp 3–167.

  15. Stafford-Smith M. Impaired haemostasis and regional anaesthesia. Can J Anaesth. 1996;43:R129–41.

    Article  CAS  PubMed  Google Scholar 

  16. Yokoyama M. Antiplatelet drug, anticoagulation therapy, and epidural anesthesia (in Japanese with English abstract). J Jpn Soc Clin Anesth. 2010;30:142–50.

    Article  Google Scholar 

  17. Liu SS, Wu CL. Effect of postoperative analgesia on major postoperative complications: a systematic update of the evidence. Anesth Analg. 2007;104:689–702.

    Article  CAS  PubMed  Google Scholar 

  18. Beattie WS, Badner NH, Choi PT. Meta-analysis demonstrates statistically significant reduction in postoperative myocardial infarction with the use of thoracic epidural analgesia. Anesth Analg. 2003;97:919–20.

    Article  PubMed  Google Scholar 

  19. Kato K, Shinjo Y, Yoshikawa K, Yonei A. A case report of a DES-implanted patient: continuation of antiplatelet therapy would prevent stent thrombosis after surgery (in Japanese with English abstract). J Jpn Soc Clin Anesth. 2011;31:986–9.

    Article  Google Scholar 

  20. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009;119:987–95.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

Ryu Kanzaki and the co-authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayoshi Inoue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanzaki, R., Inoue, M., Minami, M. et al. Feasibility of aspirin continuation during the perioperative period for pulmonary resection in lung cancer patients: a retrospective study at a single institute in Japan. Surg Today 44, 2243–2248 (2014). https://doi.org/10.1007/s00595-014-0843-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-014-0843-2

Keywords

Navigation